reninangiotensin
system
ra
critic
regul
hypertens
primarili
action
vasoact
peptid
ang
ii
gener
action
angiotensinconvert
enzym
ace
mediat
increas
blood
pressur
discoveri
primarili
metabolis
ang
ii
vasodilatori
ang
ad
new
dimens
tradit
ra
result
huge
interest
past
decad
potenti
therapeut
lower
blood
pressur
especi
elev
result
excess
ang
ii
studi
focus
help
reveal
action
ang
outsid
vasodil
antifibrot
antiprolif
effect
moreov
investig
focus
reveal
varieti
role
catalyt
also
viral
receptor
amino
acid
transport
paper
focus
known
biolog
role
pay
particular
attent
regul
express
light
entranc
human
recombin
clinic
trial
discuss
potenti
use
therapeut
highlight
pertin
question
still
remain
unansw
angiotensinconvert
serendipit
discov
ten
year
ago
neither
two
group
centr
discoveri
could
guess
disproportion
number
distinct
role
play
biolog
cardiovascular
regul
viral
infect
often
happen
modern
biolog
research
two
independ
approach
converg
discoveri
give
us
angiotensinconvert
enzym
homologu
aceh
back
past
ten
year
knowledg
protein
role
bodi
increas
exponenti
result
recombin
protein
enter
clinic
trial
back
paper
focu
current
know
regul
highlight
gap
discrep
still
remain
knowledg
initi
hypothesis
counterbalanc
action
ace
ang
also
metabolis
ace
therefor
compet
ang
activ
site
thu
provid
novel
regulatori
arm
ra
figur
studi
reveal
hydrolys
number
substrat
preferenti
cleav
termin
amino
acid
peptid
end
prox
x
hydrophob
amino
acid
hydrolysi
substrat
chloridedepend
case
ace
structur
basi
select
propos
biolog
activ
peptid
cleav
relev
ang
ii
order
understand
biolog
relev
inhibitor
develop
base
ctermin
dipeptid
hisleu
ang
allow
develop
potent
specif
inhibitor
use
numer
studi
action
vivo
vitro
although
compound
current
commerci
avail
elucid
structur
subsequ
compar
model
studi
explain
distinct
specif
reveal
subtl
differ
activ
site
ace
singl
amino
acid
substitut
steric
hinder
entranc
penultim
substrat
amino
acid
activ
site
therebi
elimin
acelik
peptidyldipeptidas
activ
substrat
specif
clarifi
shown
much
higher
catalyt
effici
hydrolysi
ang
ii
compar
ang
condit
elev
ang
concentr
patient
ace
inhibitor
therapi
convers
ang
ang
figur
like
physiolog
signific
revel
main
product
catalyt
activ
ang
figur
vasodilatori
peptid
led
complet
reevalu
therapeut
potenti
current
strategi
aim
upregul
express
activ
technic
complex
enzym
inhibit
rule
potenti
applic
inhibitor
recent
propos
possibl
antiinflammatori
initi
unsuccess
test
potenti
antiobes
drug
main
tissu
site
express
origin
identifi
testi
heart
kidney
shown
localis
apic
membran
polaris
cell
wherea
ace
equal
distribut
apic
basolater
membran
molecular
basi
differenti
local
address
presum
relat
determin
ctermin
domain
structur
membran
topolog
somat
ace
collectrin
protein
type
integralmembran
protein
ntermin
ectodomain
transmembran
region
short
ctermin
cytoplasm
tail
residu
number
indic
ace
contain
zincbind
motif
hemgh
form
activ
site
enzym
somat
ace
two
activ
site
wherea
one
collectrin
contain
catalyt
residu
homolog
ntermin
ectodomain
ace
homolog
ctermin
cytoplasm
domain
instead
share
number
residu
intracellular
domain
collectrin
signal
peptid
light
grey
transmembran
domain
textur
grey
cytoplasm
tail
two
enzym
quit
distinct
sequenc
tissu
distribut
catalogu
wide
exampl
liver
intestin
lung
recent
local
brain
appear
act
central
regul
cardiovascular
function
type
transmembran
protein
nterminu
outsid
cterminu
intracellular
predominantli
localis
endotheli
cell
catalyt
site
like
ace
expos
socal
ectoenzym
circul
vasoact
peptid
activ
therefor
modul
via
express
cell
surfac
express
level
also
cleavag
cell
membran
cleavag
shed
releas
catalyt
activ
ectodomain
stimul
exampl
phorbol
ester
mediat
disintegrin
metalloproteas
adam
ace
also
undergo
constitut
regul
shed
cell
surfac
plasma
although
enzym
respons
case
identifi
success
ace
inhibitor
shown
ang
ii
key
mediat
hypertens
henc
metabolis
ang
ii
ang
crucial
modul
blood
pressur
role
hypertens
clarifi
overexpress
vivo
reduc
blood
pressur
hypertens
model
normotens
anim
reduct
blood
pressur
may
result
increas
sensit
baroreflex
seen
upon
deliveri
hypertens
model
reduct
neuron
induc
hypertens
observ
transgen
mice
central
blood
pressur
regul
control
part
action
ang
ii
ang
ii
act
desensitis
baroreflex
stimul
water
uptak
increas
vasopressin
releas
sympathet
activ
ultim
lead
increas
blood
pressur
action
ang
ii
part
modul
increas
baroreflex
sensit
mediat
ang
comparison
hypertens
model
normotens
rodent
reveal
decreas
protein
express
brain
hypertens
model
moreov
overexpress
brain
attenu
hypertens
via
increas
nitric
oxid
product
improv
baroreflex
accordingli
inject
inhibitor
brain
rodent
attenu
baroreflex
sitespecif
overexpress
locu
control
intern
journal
hypertens
sympathet
nerv
activ
reduc
overal
hypertens
state
rat
review
role
central
blood
pressur
regul
see
soon
discoveri
gene
delet
studi
establish
modul
blood
pressur
also
essenti
regul
cardiovascular
function
progress
cardiac
dysfunct
observ
first
mous
knockout
model
resembl
tissu
subject
longterm
hypoxia
type
occur
coronari
arteri
diseas
bypass
surgeri
human
result
observ
immedi
propos
cardioprotect
protein
hypothesi
strengthen
observ
phenotyp
revers
concurr
knockout
ace
gene
evid
appear
demonstr
unequivoc
primari
role
counterbal
ace
initi
hypothesi
play
critic
role
cardiac
function
primarili
counterbalanc
effect
ace
howev
entir
support
subsequ
gene
delet
model
discrep
initi
studi
phenotyp
describ
elsewher
saw
obviou
function
morpholog
chang
initi
propos
due
differ
genet
background
model
potenti
mechan
investig
backcross
hybrid
model
use
studi
initi
parent
line
howev
backcross
model
show
cardiac
chang
interestingli
subsequ
studi
use
origin
mice
describ
crackow
et
al
also
show
overt
cardiac
chang
suggest
phenotyp
lost
time
despit
see
overt
phenotyp
chang
delet
model
subsequ
group
shown
reduc
abil
respond
injuri
mice
togeth
studi
suggest
rather
key
mediat
cardiac
phenotyp
essenti
modul
respons
injuri
fact
delet
model
significantli
higher
mortal
rate
myocardi
infarct
mi
wildtyp
mice
associ
advers
ventricular
remodel
worsen
ventricular
function
follow
mi
increas
matrix
activ
free
radic
product
upregul
proinflammatori
cytokin
heart
mice
postul
mediat
advers
remodel
mi
event
advers
remodel
caus
revers
upon
administr
blocker
therefor
patholog
delet
state
injuri
attribut
part
increas
local
level
ang
ii
abil
improv
respons
injuri
result
clear
ang
ii
therebi
limit
patholog
potenti
also
produc
ang
convers
ang
ii
ang
physiolog
rout
ang
product
exampl
zinc
metallopeptidas
neprilysin
nep
convert
ang
ang
effici
ace
nep
convert
ang
ang
rel
import
variou
enzym
ang
product
vari
depend
rel
express
level
differ
tissu
eg
kidney
versu
heart
versu
brain
physiolog
statu
like
ang
ii
action
ang
extend
beyond
vasopressor
control
infus
ang
reduc
interstiti
fibrosi
ang
iiindepend
ang
iidepend
hypertens
interestingli
studi
effect
blood
pressur
hypertens
anim
infus
chronic
level
ang
howev
discrep
effect
ang
cardiac
hypertrophi
two
studi
ang
effect
saltinduc
hypertrophi
ang
iiindepend
hypertens
significantli
reduc
myocyt
hypertrophi
ang
iiinduc
hypertens
cardiacspecif
overexpress
ang
observ
reduc
hypertroph
respons
ang
ii
concurr
reduct
hypertroph
marker
atrial
natriuret
peptid
brain
natriuret
peptid
transcript
level
activ
hypertroph
signal
pathway
csrc
mapk
ang
inhibit
myocyt
cell
growth
vitro
action
ma
receptor
accordingli
prevent
ventricular
hypertrophi
vivo
stimul
myocardi
infarct
mi
reduct
myocyt
diamet
ventricular
weight
mice
viral
express
ang
associ
decreas
proinflammatori
cytokin
compar
control
worth
note
ang
overexpress
slightli
reduc
exogen
ace
mrna
level
ablat
approxim
twofold
increas
express
result
mi
whilst
increas
express
level
respons
mi
level
consist
shown
alter
cardiovascular
diseas
state
light
counterbalanc
hypothesi
could
presum
sinc
ace
consist
report
increas
damag
cardiac
tissu
level
would
also
increas
homeostat
respons
offset
rise
ang
ii
concentr
hypothet
upregul
support
evid
human
nonischaem
cardiomyopathi
consist
shown
increas
level
fail
human
heart
compar
control
patient
howev
contrast
ischaem
cardiomyopathi
current
conflict
evid
chang
express
level
upregul
seen
studi
mechan
damageinduc
increas
investig
use
vivo
model
mi
upregul
repeatedli
shown
rat
model
mi
discrep
mrna
protein
level
seen
infarct
zone
suggest
increas
protein
mediat
posttranscript
mechan
howev
timecours
investig
reveal
increas
seen
eight
week
mi
follow
decreas
express
mi
model
compar
control
week
although
entir
consist
result
balanc
seem
indic
compensatori
role
condit
myocardi
injuri
given
role
remov
ang
ii
identifi
candid
gene
underli
loci
link
hypertens
follow
initi
map
x
chromosom
comparison
express
level
kidney
three
rat
strain
show
express
intern
journal
hypertens
lower
hypertensivepron
strain
moreov
express
decreas
significantli
hypertens
initi
saltsensit
hypertens
rat
decreas
endogen
express
note
spontan
hypertens
rat
compar
wistarkyoto
initi
studi
see
genet
chang
associ
gene
hypertens
strain
support
subsequ
data
fail
show
link
polymorph
hypertens
abundantli
express
kidney
express
invers
correl
hypertens
local
ra
within
kidney
activ
hyperglycem
condit
model
environ
type
diabet
studi
use
model
type
diabet
shown
earli
stage
prior
diabet
nephropathi
develop
express
reduc
kidney
ace
express
elev
similarli
model
type
diabet
express
elev
earli
decreas
late
stage
diabet
nephropathi
addit
studi
human
sampl
shown
de
novo
express
glomerular
endothelium
mesangi
cell
diabet
patient
howev
express
seen
type
diabet
renal
biopsi
one
studi
carri
take
biopsi
twenti
type
diabet
patient
twenti
healthi
donor
show
decreas
increas
ace
tubulointerstitium
glomeruli
diabet
patient
nephropathi
indic
patholog
import
balanc
two
enzym
hypothesi
kidney
diseas
pathogenesi
diabet
mediat
upregul
ace
downregul
origin
suggest
mizuiri
et
al
heart
loss
kidney
associ
increas
suscept
injuri
mice
shown
enhanc
suscept
glomerulosclerosi
coupl
increas
collagen
fibronectin
deposit
filtrat
dysfunct
evidenc
urinari
albumin
pronounc
male
mice
wherea
femal
mice
appear
protect
pharmacolog
inhibit
shown
similar
effect
increas
urinari
albumin
mesangi
cell
expans
vascular
thick
type
type
diabet
model
studi
attribut
patholog
seen
lost
increas
level
ang
ii
order
confirm
renoprotect
role
akita
mice
type
model
diabet
cross
mice
kidney
function
observ
model
show
increas
urinari
albumin
glomerular
basement
membran
thick
fibronectin
smooth
muscl
compar
diabet
mice
express
surprisingli
see
chang
ang
ii
diabet
model
despit
show
use
ang
ii
receptor
blocker
abl
attenu
marker
glomerular
injuri
urinari
albumin
seen
knockout
diabet
mice
convers
delet
disrupt
benefit
ace
inhibit
diabet
nephropathi
streptozotocininduc
diabet
suggest
ace
inhibit
may
enhanc
activ
interestingli
diabet
model
ang
infus
result
pronounc
renal
injuri
may
contradictori
first
appear
also
saw
downregul
ma
receptor
propos
receptor
ang
current
find
suggest
may
particip
compensatori
mechan
diabet
kidney
prior
onset
diabet
nephropathi
direct
involv
diabet
pancreat
express
investig
express
elev
islet
type
diabet
rat
correl
increas
ace
collagen
iv
level
mice
significantli
increas
fast
blood
glucos
compar
wildtyp
litterm
direct
role
pancrea
yet
identifi
contrast
homologu
collectrin
heavili
implic
insulin
exocytosi
discov
collectrin
excit
interest
due
high
homolog
cytoplasm
tail
sirna
knockdown
collectrin
result
reduct
insulin
exocytosi
insulinsecret
cell
vivo
overexpress
collectrin
led
signific
increas
insulin
secret
collectrin
implic
insulin
secretori
pathway
associ
collectrin
snapin
part
snare
complex
howev
collectrinknockout
mice
reveal
differ
insulin
secret
wildtyp
decreas
insulin
sensit
homolog
ace
chimaera
ace
close
homolog
catalyt
domain
nterminu
collectrin
close
resembl
transmembran
intracellular
ctermin
domain
figur
collectrin
first
identifi
unknown
protein
upregul
model
partial
nephrectomi
function
remain
elus
four
year
crystal
tyrosin
phenylalanin
detect
urin
collectrinnul
mice
investig
reveal
level
neutral
amino
acid
transport
b
reach
plasma
membran
significantli
decreas
collectrinnul
mice
suggest
collectrin
may
act
molecular
chaperon
b
kidney
implic
similar
role
close
homolog
eleg
set
studi
subsequ
reveal
fact
act
molecular
chaperon
b
small
intestin
collectrin
express
interact
shown
underli
patholog
aminoaciduria
seen
hartnup
disord
hartnup
disord
caus
mutat
outer
edg
b
result
failur
reach
plasma
membran
reveal
mutat
disrupt
complex
therefor
prevent
act
molecular
chaperon
deliv
transport
intestin
brush
border
membran
outsid
cardiovascular
system
anoth
noncatalyt
function
previous
shown
new
diseas
term
sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
sarscov
spread
quickli
around
world
caus
death
identifi
receptor
sar
viru
vitro
also
act
receptor
viru
soon
studi
confirm
essenti
sar
infect
vivo
use
mice
concurr
discov
protect
murin
lung
sever
acut
injuri
subsequ
sarscov
infect
sar
spike
protein
downregul
express
figur
mention
circumstanti
entir
consist
evid
literatur
ace
coregul
human
hypertens
patient
level
lower
kidney
heart
compar
normotens
volunt
grow
bodi
vitro
evid
suggest
decreas
mediat
least
part
ang
ii
propos
mechan
involv
signal
via
map
andor
elev
jnk
phosphoryl
furthermor
administr
blocker
shown
result
increas
level
link
regul
ace
catalyt
product
ace
ang
ii
regul
howev
role
ang
ii
play
regul
yet
fulli
elucid
despit
decreas
express
respons
ang
ii
model
evid
ang
iimedi
increas
hepat
stellat
cell
rel
littl
known
detail
transcript
regul
although
angiotensin
peptid
well
peptid
steroid
hormon
appear
modul
express
studi
done
factor
may
control
regul
hormon
oxygen
level
exampl
although
hypoxia
decreas
transcript
investig
reveal
hypoxiainduc
increas
ace
express
turn
lead
increas
concentr
ang
ii
ang
ii
mediat
decreas
ang
also
shown
affect
express
cardiac
renal
decreas
hypertens
normotens
rat
model
respons
ang
infus
although
effect
blood
pressur
demonstr
mechan
action
propos
administr
aldosteron
rat
myocyt
also
shown
downregul
mrna
level
micromolar
concentr
aldosteron
shown
decreas
mrna
express
significantli
myocyt
hormoneinfus
rat
although
contrast
model
chang
mrna
level
seen
rat
infus
ang
ii
treat
myocyt
isol
neonat
rat
decreas
express
via
signal
decreas
block
cotreat
ang
effect
oestrogen
express
recent
also
explor
light
clinic
evid
establish
hormon
replac
therapi
protect
cardiovascular
diseas
treat
rat
oestrogen
shown
reduc
cardiac
remodel
interstiti
fibrosi
previou
vitro
studi
shown
oestradiol
treatment
protect
ang
iiinduc
fibroblast
prolifer
benefici
effect
oestrogen
coupl
dosedepend
increas
signific
chang
blood
pressur
seen
protect
mechan
propos
compon
ra
also
express
adipos
tissu
highfat
diet
shown
increas
mrna
level
mous
adipocyt
vivo
vitro
although
chang
evid
adipos
tissu
mice
heart
failur
tissu
cultur
model
adipos
differenti
shown
increas
mrna
time
accompani
increas
adam
increas
activ
thu
activ
level
remain
constant
via
coregul
adam
cleav
cell
membran
increas
express
report
adipos
tissu
rat
fed
highsucros
diet
although
preliminari
form
effect
alltransretino
acid
investig
express
reveal
increas
mrna
level
reportedli
protein
decreas
blood
pressur
treat
rat
also
seen
attribut
increas
level
subject
posttransl
modif
glycosyl
phosphoryl
also
subject
posttransl
regul
releas
cell
membran
shed
action
adam
describ
cleavag
occur
juxtamembran
region
short
peptid
mimic
around
like
cleavag
site
region
hydrolys
recombin
adam
argser
bond
correspond
arg
ser
sequencedepend
manner
howev
mutat
critic
cleavag
residu
cellbas
system
fail
inhibit
shed
suggest
specif
adam
topograph
determin
rather
sequenc
depend
function
catalyt
activ
solubl
shed
form
unknown
although
protein
exampl
amyloid
precursor
protein
acetylcholinesteras
releas
protein
act
ligand
stimul
cellcel
interact
retent
cell
membran
regul
calmodulin
bind
inhibit
calmodulin
bind
increas
cellular
releas
elev
level
shed
associ
increas
myocardi
dysfunct
catalyt
activ
shed
may
mask
presenc
endogen
inhibitor
plasma
current
remain
uncharacteris
previous
mention
sar
viru
downregul
cellular
express
bind
sar
spike
protein
induc
shed
ntermin
domain
figur
shed
report
differ
group
essenti
viral
replic
unnecessari
sar
viru
undergo
clathrindepend
endocytosi
upon
receptor
bind
process
internalis
sar
viru
receptor
clear
cell
membran
figur
henc
allow
enhanc
damag
reactiv
toward
circul
ang
ii
contrast
ectodomain
shed
cytoplasm
domain
appear
play
role
regul
internalis
current
pertin
question
whether
go
use
therapeut
target
far
data
suggest
increas
express
would
benefici
number
diseas
increas
level
achiev
viral
deliveri
applic
alloster
activ
catalysi
administr
human
recombin
asid
effect
hypertens
viral
overexpress
shown
reduc
collagen
product
cultur
fibroblast
well
inhibit
angiiinduc
fibrosi
hypertrophi
vivo
stabilis
atherosclerot
plaqu
renoprotect
viral
deliveri
induct
myocardi
infarct
protect
reduc
advers
cardiac
remodel
fibrosi
similar
antifibrot
effect
seen
activ
along
attenu
angiiinduc
thrombu
hypertens
rat
modest
reduct
blood
pressur
spontan
hypertens
rat
past
month
number
studi
carri
examin
effect
recombin
human
rang
diseas
condit
date
administr
mous
model
angiiinduc
diseas
shown
revers
patholog
effect
ang
ii
diabet
nephropathi
heart
diseas
renal
oxid
stress
well
revers
angiiinduc
hypertens
interestingli
infus
appear
effect
nondiseas
state
basal
level
ang
ii
wildtyp
mice
mice
make
potenti
valuabl
therapeut
fundament
question
cellular
biolog
remain
evid
paper
question
need
answer
underli
mechan
regul
could
help
clarifi
understand
ra
whole
exampl
antagonist
transcript
factor
regul
ace
compon
ra
coordin
regul
signal
pathway
microrna
regul
ra
coordin
cytokin
modifi
express
posttransl
chang
apart
shed
regul
includ
phosphoryl
ubiquitin
analog
provid
regul
ace
ace
known
signal
phosphoryl
cytoplasm
tail
modul
retent
cell
membran
also
mediat
transmembran
signal
increas
transcript
respons
ace
inhibitor
exogen
ace
shown
transcript
effect
independ
catalyt
activ
vsmc
endotheli
cell
treat
ace
cytoplasm
tail
despit
share
homolog
ace
similar
signal
properti
ace
shed
membran
releas
ectodomain
fate
ectodomain
unknown
may
mechan
rapid
clearanc
perhap
ectodomain
endocytos
traffick
nucleu
elicit
transcript
chang
shown
exogen
ace
matter
destini
retain
cytoplasm
section
protein
known
intracellular
domain
shed
protein
app
notch
releas
cleavag
initi
adam
ectodomain
cleavag
process
refer
intramembran
proteolysi
intracellular
domain
app
notch
travel
nucleu
stabilis
chaperon
elicit
transcript
chang
perhap
similar
fate
await
ace
intracellular
domain
gener
novel
role
may
yet
remain
discov
new
twist
stori
emerg
discoveri
autoantibodi
target
sera
patient
connect
tissu
diseas
coupl
result
show
administr
inhibitor
improv
patholog
inflammatori
bowel
diseas
suggest
inhibit
may
benefici
inflammatori
diseas
arthriti
divers
role
continu
surpris
field
given
appar
success
recombin
human
anim
model
could
valuabl
therapeut
howev
worth
note
far
diseas
model
recombin
shown
success
type
diabet
studi
yet
shown
revers
effect
exogen
ang
ii
infus
work
done
hypertensivepron
model
viral
deliveri
activatormedi
induct
hard
judg
clinic
relev
treatment
although
immun
respons
recombin
viral
deliveri
system
report
upon
infus
rodent
alway
concern
strategi
given
caveat
perhap
prioriti
focu
futur
research
upregul
endogen
gene
express
catalyt
activ
highlight
paper
work
requir
determin
divers
role
interlink
order
allow
chronic
modul
level
proceed
confid
